JCRB0326 XP39OS
Cell information
Important Notice(s)Cell type：human mutant cell repository from Kyoto University (View Pricing Information)
| JCRB No. | JCRB0326 | Cell Name | XP39OS |
|---|---|---|---|
| Profile | Hereditary disease with high cancer risk xeroderma pigmentosum (autosomal recessive) complementation group A skin fibroblast. | Other Name | |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | F | Age | 7 |
| Identity | available | Tissue for Primary Cancer | |
| Case history | Metastasis | ||
| Tissue Metastasized | Genetics | 46,XX | |
| Life Span | finite | Crisis PDL | |
| Morphology | fibroblast-like | Character | Xeroderma pigmentosum (A), fibroblast |
| Classify | primary | Established by | Ikenaga,M. |
| Registered by | Sasaki,M. | Regulation for Distribution | |
| Comment | Year | 1988 | |
| Medium | RPMI1640 medium, 20% non-heat-inactivated fetal bovine serum. (establish: alpha-MEM medium with 20% fetal calf serum) | Methods for Passages | Replate every 7-10 days. Trypsin-EDTA treatment and 1/2 dilution. |
| Cell Number on Passage | 5-2x10^6 cells/100mm dish | Race | Japanese |
| CO2 Conc. | 5 % | Tissue Sampling | skin |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
| CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
| EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
| HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
| HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | - | ||||||
| Notes | |||||||||
| Reference | |
|---|---|
| Pubmed id:3814505 | Sensitivity to UV radiation of fibroblasts from a Japanese group A xeroderma pigmentosum patient with mild neurological abnormalities. Sato K,Watatani M,Ikenaga M,Kozuka T,Kitano Y,Yoshikawa K,Mimaki T,Abe J,Sugita T Br J Dermatol. 1987 Jan;116(1):101-8 |
| Images |
|---|
         |
LOT Information
| Cell No. | JCRB0326 | Cell Name | XP39OS |
|---|---|---|---|
| LOT No. | 04262011 | Lot Specification | distribution |
| Medium | RPMI1640 medium(GIBCO) with 20% fetal bovine serum(SIGMA027K03911,non HI) | Temperature | 37 C |
| Cell Density at Seeding | 1.1-3.3x10^4 cells/sq.cm | Methods for Passages | Cells were harvested after treatment with 0.25%trypsin(GIBCO) and 0.02% EDTA. |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 2.02x10^6 |
| Viability at cell freezing (%) | 99.1 | Antibiotics Used | free |
| Passage Number | p14 | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | NT |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | D5S818:11,12 D13S317:9,11 D7S820:11,12 D16S539:10,12 VWA:17,18 TH01:6,7 AM:X TPOX:8,11 CSF1PO:12 |
| Adhesion | Yes | Exoteric Gene | NT |
| Medium for Freezing | Cell Banker BLC-1(Nihon Zenyaku Industries) | CO2 Conc. | 5 % |
| Viability immediately after thawing (%) | Additional information |
| Images |
|---|
|
|